# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-022739
Filing Date
2019-11-12
Accepted
2019-11-12 08:01:40
Documents
90
Period of Report
2019-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0919_immucellcorporation.htm | 10-Q | 610931
2 | CERTIFICATION | f10q0919ex31_immucellcorp.htm | EX-31 | 8453
3 | CERTIFICATION | f10q0919ex32_immucellcorp.htm | EX-32 | 4443
| Complete submission text file | 0001213900-19-022739.txt |  | 4676479

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL INSTANCE FILE | iccc-20190930.xml | EX-101.INS | 865379
5 | XBRL SCHEMA FILE | iccc-20190930.xsd | EX-101.SCH | 58021
6 | XBRL CALCULATION FILE | iccc-20190930_cal.xml | EX-101.CAL | 70381
7 | XBRL DEFINITION FILE | iccc-20190930_def.xml | EX-101.DEF | 186715
8 | XBRL LABEL FILE | iccc-20190930_lab.xml | EX-101.LAB | 422783
9 | XBRL PRESENTATION FILE | iccc-20190930_pre.xml | EX-101.PRE | 329834

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 191206228
SIC: 2835 In Vitro & In Vivo Diagnostic Substances